Russia has announced that it is ready to roll out immunization for its COVID-19 vaccine in October, despite it not having completed Phase III trials. It has also published peer reviewed Phase I/II trial data in The Lancet.
Named Sputnik V – the ‘V’ standing for vaccine - the adenovirus-based product was granted provisional approval in Russia on...







![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)